1. IMMU-13. Dual CTLA4/ PD-1 blockade improves survival for replication-repair deficient high-grade gliomas failing single agent PD-1 inhibition: An IRRDC study. (3rd June 2022) Authors: Das, Anirban; Morgenstern, Daniel; Bianchi, Vanessa; Sudhaman, Sumedha; Edwards, Melissa; Stengs, Lucie; Larouche, Valerie; Samuel, David; Van Damme, An; Gass, David; Ziegler, David; Bielack, Stefan; Zelcer, Shayna; Yalon, Michal; Constantini, Shlomi; Sarosiek, Tomasz; Libionka, Witold; Nichols, ... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 1 Page Start: i84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗